Skip to main content
. 2018 May 18;217(Suppl 1):S75–S80. doi: 10.1093/infdis/jix603

Table 2.

Baseline Medical Conditions Reported by Safety Substudy Participants by Medical Dictionary for Regulatory Activities System Organ Class (n = 440)

MedDRA SOC and PTa No. (%)
Congenital, familial, and genetic disorders 4 (0.9)
Eye disorders 2 (0.4)
Gastrointestinal disorders 26 (5.9)
 Gastric ulcer 13 (3.0)
 Peptic ulcer 12 (2.7)
 Other 1 (0.2)
General disorders and administration site conditions 10 (2.3)
 Ulcerb 8 (1.8)
 Other 2 (0.4)
Hepatobiliary disorders 1 (0.2)
Immune system disorders 62 (14.1)
 Drug hypersensitivity 51 (11.6)
 Food allergy 6 (1.4)
 Other 5 (1.1)
Infections and infestationsc 13 (3.0)
 Malaria 6 (1.4)
 Typhoid fever 5 (1.1)
 Other 3 (0.6)
Injury, poisoning, and procedural complications 3 (0.7)
Investigations 1 (0.2)
Musculoskeletal and connective tissue disordersc 39 (8.9)
 Arthralgia 17 (3.9)
 Arthropathy 12 (2.7)
 Other 12 (2.7)
Nervous system disorders 2 (0.5)
Respiratory, thoracic, and mediastinal disorders 3 (0.7)
Surgical and medical procedures 1 (0.2)
Vascular disorders 1 (0.2)

Abbreviations: MedDRA, Medical Dictionary for Regulatory Activities; PT, preferred term; SOC, system organ class.

aWithin each SOC, individual PTs reported by ≥1% of substudy participants are listed.

bThe organ system affected was not documented.

cThe sum of the PTs is greater than the total for the SOC because some participants in this SOC reported >1 PT.